ArticleRheumatology and therapy2024

Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.

Walter P Maksymowych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.